Theranos adds qualified medical experts and scientists to advisory board
techcrunch.com
techcrunch.com
I do wonder how involved the SAB has been given all the questions.
Edit: looking at the page I am now uncertain they had one, which would be very unusual for a life sciences company.
Most folks, when faced with the reality that their original idea won't work and they don't have any idea how to make it work, fold up the company and go back to school or get a job. Some raise $800M, stack the board of directors with politicians and generals, and try to sell to the military.
Apply HN here I come...
Their development efforts failed, and they clearly ran their lab horribly, but I don't see any evidence (or motivation) for the company being a scam from the beginning. What would their exit strategy have been if they had never intended to produce a viable innovation?
>any evidence (or motivation) for the company being a scam from the beginning. What would their exit strategy have been if they had never intended to produce a viable innovation?
it wasn't pure scam (until of course you dare to call a shady government/military contracting a "scam" :). The story goes something like that that their exit was to sell the stuff to Pentagon, and unfortunately for them and all the high powered Theranos friends there happen to be a guy who insisted on FDA approval before that.
https://www.washingtonpost.com/news/wonk/wp/2015/12/02/inter...
Very typical Theranos tactics: "Chief executive Elizabeth Holmes, the company’s superstar founder, asked an ally at the highest level of the military to squelch those “inaccurate” concerns in 2012"
The "ally" is 4-star Marine General who sits on the Theranos board right now :)
I am a woman and my experiences have been that this is a serious handicap for getting effective constructive feedback. Men don't really want to have a serious conversation with me about what works, what doesn't, why that is true, etc. If they talk to me at all, many of them are either 1) trying to be charming, even if they have no explicit goal of trying to sleep with me or 2) trying to be encouraging, as if the deeply rooted problems of sexism boil down to "girls just lack confidence!"
It has been enormously frustrating.
I am older than the woman who founded Theranos. I am older and I have had a less cushy life and I have really struggled with the question of how to get my work taken seriously and how to get men to talk to me about my actual work in an actually constructive fashion. Things have gotten better, but I look at Theranos and I suspect that there was no intent to do anything fraudulent and she may not even fully recognize that it is a failure yet, because she has been talked at for so many years by so many intelligent, successful people like she was a genius and surely was on to something big.
I really think this is the likely crux of the problem and I see no good fix for it. I still find it maddeningly difficult to get men to take my work seriously. And I have been very aware that them talking to me for the wrong reason, about the wrong things is a real problem for quite some years.
that is too, plus it is probably the other side of the same coin - i mean why risk and get into serious conversation, provide constructive feedback which in large part means criticizing and risk getting exposed to potential claim of creating a "hostile environment for females".
The following press release only mentions two other members (one of whom is the CEO). It also uses the future tense to say "Theranos’ Scientific and Medical Advisory Board will meet quarterly."
http://www.businesswire.com/news/home/20160407006056/en/Ther...
Is is appropriate to flag stories about Theranos? I doesn't seem appropriate to let them have an unfettered voice.
The reason why larger quantities of blood are routinely collected pertains not to the quantity used in the actual biochemical assay, but to the number of tests that may be carried out, and the greater ease of handling slightly larger quantities of sample than Theranos aims (aimed?) to handle. That is for their scientific model.
Their business model was based mostly on enabling blood to collected without the need for a qualified person (e.g. a phlebotomist or nurse). This they could do because the amount of blood collected, and the method of collection, circumvented existing legislation. However, if it turns out that this method of collection doesn't "scale" then it too is a wash.
Their saving grace might be if they can show that they can indeed perform assays on non-professionally collected blood to FDA-level standards. But that remains to be shown.